In one paragraphArticle in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors at 2 institutions in 2 countries.
Tiago Bordeira GasparInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-7410-7869 Tito Teles JesusInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.
Maria Teresa AzevedoInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.
Sofia MacedoInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0001-7752-998X Mariana Alves SoaresInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.
Rui Sousa MartinsInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0003-1349-3281 Rúben LeiteInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.
Lia RodriguesInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.
Daniela Ferreira RodriguesInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0003-3517-2462 Luís CardosoInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.
Inês BorgesCentro de Diagnóstico Veterinário (Cedivet), 4200-071 Porto, Portugal.
Sule CanberkInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-3736-1323 Fátima GärtnerInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-5302-0086 Leandro Miranda-AlvesLaboratório de Endocrinologia Experimental (LEEx), Instituto de Ciências Biomédicas (ICB), Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.ORCID 0000-0001-7832-8717 José Manuel LopesInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0001-8597-3474 Paula SoaresInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0001-9607-6998 João VinagreInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-0871-1427 Universidade do Porto · PTUniversidade Federal do Rio de Janeiro · BR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Atrx loss was recently ascertained as insufficient to drive pancreatic neuroendocrine tumour (PanNET) formation in mice islets. We have identified a preponderant role of Atrx in the endocrine dysfunction in a
Indexed as
Atrxconditional mouse modelendocrine dysfunctionfatty pancreashepatic stetosishyperglycaemiainflammageingobesitypancreatic fatty replacementPdx1-Cre
Identifiers
PMID37296979
PMCPMC10252256
OpenAlexW4379231292
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390